Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Illumina, Inc. - Common Stock
(NQ:
ILMN
)
100.34
+2.19 (+2.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Illumina, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
“Mag 7 Undercard Movers: IBO, SNYR, CTOR, PNPN.V, LAB – Breakthroughs in Military Defense, Tech, Medical & Healthcare Fuel Market Buzz”
June 23, 2025
Via
AB Newswire
Topics
Artificial Intelligence
SomaLogic Acquisition Marks Next Step In Illumina's Advanced Biomarker Push
June 23, 2025
Illumina will acquire SomaLogic to expand in proteomics, adding new revenue streams and accelerating tech development in multiomics.
Via
Benzinga
1 of Wall Street’s Favorite Stock to Target This Week and 2 to Brush Off
June 20, 2025
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...
Via
StockStory
Topics
Energy
3 Reasons ILMN is Risky and 1 Stock to Buy Instead
June 18, 2025
What a brutal six months it’s been for Illumina. The stock has dropped 33.6% and now trades at $89.03, rattling many shareholders. This may have investors wondering how to approach the situation.
Via
StockStory
Earnings Scheduled For May 8, 2025
May 08, 2025
Via
Benzinga
Retail Investors Flock To Incyte As Drug Data, Qiagen Deal Fuel Optimism
June 16, 2025
Stifel also upgraded the stock to ‘Buy’ with a $107 price target.
Via
Stocktwits
Datadog To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday
June 11, 2025
Via
Benzinga
Breaking Down Illumina: 11 Analysts Share Their Views
June 11, 2025
Via
Benzinga
3 Mid-Cap Stocks Walking a Fine Line
June 11, 2025
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from...
Via
StockStory
ILMN Q1 Earnings Call: Clinical Growth and Cost Actions Offset Research and China Headwinds
June 10, 2025
Genomics company Illumina (NASDAQ:ILMN) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 1.4% year on year to $1.04 billion. Its non-GAAP profit of $0.97 per...
Via
StockStory
Topics
Economy
World Trade
Cathie Wood Sells Tesla Stock As Chinese Rivals Gain Ground — Ark Dumps Palantir Amid Privacy Concerns
June 02, 2025
On Monday, Cathie Wood-led Ark Invest sold shares of Tesla and Palantir, amidst competition and data misuse concerns. Ark also made significant trades in other companies, such as eToro and Illumina.
Via
Benzinga
Cathie Wood Reiterates 'Profound' AI Application In Healthcare As Researchers Discover 'Cancer Survival Outcomes' By Facial Photograph Analysis: Here Are The Stocks That Could Benefit
May 26, 2025
Cathie Wood underscored the application of AI in the healthcare sector by sharing new research by Mass General Brigham.
Via
Benzinga
Topics
Artificial Intelligence
Life Sciences Tools & Services Stocks Q1 Recap: Benchmarking Illumina (NASDAQ:ILMN)
May 25, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Danaher, Illumina, Globalstar, and Insperity Shares Plummet, What You Need To Know
May 21, 2025
A number of stocks fell in the afternoon session after the major indices fell further in the afternoon (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft...
Via
StockStory
Topics
Bonds
Stocks
What 15 Analyst Ratings Have To Say About Illumina
May 20, 2025
Via
Benzinga
Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal
May 19, 2025
Regeneron (REGN) to acquire 23andMe for $256 million, plans to maintain consumer services and uphold privacy policies. Deal expected to close Q3 2025.
Via
Benzinga
Icahn Ramps Up Bets On Genes And Jets: Illumina Stake Jumps 450%, JetBlue Holding Grow 90%
May 16, 2025
Carl Icahn boosts holdings in Illumina and JetBlue, showing confidence in biotech and airlines. He also trims exposure to Southwest Gas Holdings.
Via
Benzinga
3 Volatile Stocks with Mounting Challenges
May 13, 2025
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.
Via
StockStory
Illumina Analysts Lower Their Forecasts After Q1 Results
May 12, 2025
Via
Benzinga
Cathie Wood Says AI Innovation In Healthcare Will Be More 'Profound' Than Autonomous Taxi Networks, Humanoid Robots
May 12, 2025
Cathie Wood highlights the rising applications of AI and how it is poised to impact the health care space.
Via
Benzinga
Topics
Artificial Intelligence
10 Health Care Stocks With Whale Alerts In Today's Session
May 09, 2025
Via
Benzinga
Illumina’s (NASDAQ:ILMN) Q1 Sales Top Estimates
May 08, 2025
Genomics company Illumina (NASDAQ:ILMN) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 1.4% year on year to $1.04 billion. Its non-GAAP profit of $0.97 per share...
Via
StockStory
Earnings To Watch: Illumina (ILMN) Reports Q1 Results Tomorrow
May 06, 2025
Genomics company Illumina (NASDAQ:ILMN) will be announcing earnings results this Thursday afternoon. Here’s what to expect.
Via
StockStory
Assessing Illumina: Insights From 16 Financial Analysts
April 29, 2025
Via
Benzinga
Rep. Thomas Kean Has Bought Up to $45K Worth Of Illumina Stock: Here's What You Should Know
April 21, 2025
Via
Benzinga
Q4 Rundown: Illumina (NASDAQ:ILMN) Vs Other Life Sciences Tools & Services Stocks
April 18, 2025
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Illumina (NASDAQ:ILMN) and the...
Via
StockStory
Topics
Artificial Intelligence
Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations
April 16, 2025
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:ILMN),(NASDAQ:TEM),(NYSE:MDT),(NASDAQ:MDAI) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
1 Healthcare Stock for Long-Term Investors and 2 to Keep Off Your Radar
April 11, 2025
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID...
Via
StockStory
Topics
Stocks
Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations
April 16, 2025
From
FN Media Group LLC
Via
GlobeNewswire
Got $3,000? 2 Artificial Intelligence (AI) Stocks to Buy and Hold for the Long Term
April 09, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.